OptimizeRx (OPRX) Non-Current Deferred Tax Liability (2018 - 2026)

OptimizeRx has disclosed Non-Current Deferred Tax Liability across 9 years of filings, most recently posting $5.5 million for Q2 2026.

• In Q2 2026, Non-Current Deferred Tax Liability rose 59.66% year-over-year to $5.5 million; the TTM figure through Jun 2026 stood at $5.5 million (up 59.66% YoY), while the FY2025 annual figure was $5.7 million, down 52.24% from the prior year.
• Non-Current Deferred Tax Liability came in at $5.5 million for Q2 2026 at OptimizeRx, down from $5.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $11.9 million in Q4 2024 to a low of $2.3 million in Q4 2022.
• Average Non-Current Deferred Tax Liability over 5 years is $4.9 million, with a median of $4.3 million recorded in 2023.
• Year-over-year, Non-Current Deferred Tax Liability soared 175.4% in 2024 and tumbled 52.24% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $2.3 million in 2022, then jumped by 86.14% to $4.3 million in 2023, then soared by 175.4% to $11.9 million in 2024, then plunged by 52.24% to $5.7 million in 2025, then fell by 3.23% to $5.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $5.5 million in Q2 2026, $5.7 million in Q1 2026, and $5.7 million in Q4 2025.